Skip to main content

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in STOK — Stoke Therapeutics, Inc.

CIK 861177 NEW YORK, NY

Position in STOK

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,134,258
+$239,755 QoQ
Shares Held
65,228
+12.1% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 198 holders
Holding Since
Mar 2023
12 quarters on record
Voting authority Sole 46% Shared 0% None 54%

Common Shares in STOK Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. STOK ranks #97 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in STOK

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,134,258 65,228
2026-03-31 $1,894,503 58,185
2025-12-31 $1,815,908 57,212
2025-09-30 $1,782,663 75,858
2025-06-30 $1,217,173 107,240
2025-03-31 $550,632 82,802
2024-12-31 $1,053,419 95,505
2024-09-30 $524,684 42,692
2024-06-30 $775,459 57,399
2023-09-30 $44,907 11,398
2023-06-30 $121,160 11,398
2023-03-31 $94,944 11,398